176 related articles for article (PubMed ID: 28694021)
1. Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity.
Wang L; Jiang R; Liu Y; Cheng M; Wu Q; Sun XL
J Biosci Bioeng; 2017 Oct; 124(4):445-451. PubMed ID: 28694021
[TBL] [Abstract][Full Text] [Related]
2. End-point modification of recombinant thrombomodulin with enhanced stability and anticoagulant activity.
Liu X; Boron M; Zhao Y; Sun XL
Eur J Pharm Sci; 2019 Nov; 139():105066. PubMed ID: 31513922
[TBL] [Abstract][Full Text] [Related]
3. Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.
Zhang H; Weingart J; Jiang R; Peng J; Wu Q; Sun XL
Bioconjug Chem; 2013 Apr; 24(4):550-9. PubMed ID: 23458546
[TBL] [Abstract][Full Text] [Related]
4. Preparation of chain-end clickable recombinant protein and its bio-orthogonal modification.
Wang L; Jiang R; Wang L; Liu Y; Sun XL
Bioorg Chem; 2016 Apr; 65():159-66. PubMed ID: 26953841
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains.
Nawa K; Ono M; Fujiwara H; Sugiyama N; Uchiyama T; Marumoto Y
Biochim Biophys Acta; 1994 Apr; 1205(2):162-70. PubMed ID: 7512385
[TBL] [Abstract][Full Text] [Related]
7. Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities.
Gasper PM; Fuglestad B; Komives EA; Markwick PR; McCammon JA
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21216-22. PubMed ID: 23197839
[TBL] [Abstract][Full Text] [Related]
8. Investigation of cofactor activities of endothelial microparticle-thrombomodulin with liposomal surrogate.
Gruzdys V; Wang L; Wang D; Huang R; Sun XL
Biochem Biophys Res Commun; 2023 Apr; 651():79-84. PubMed ID: 36801612
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.
Handley LD; Treuheit NA; Venkatesh VJ; Komives EA
Biochemistry; 2015 Nov; 54(43):6650-8. PubMed ID: 26468766
[TBL] [Abstract][Full Text] [Related]
10. The role of thrombomodulin lectin-like domain in inflammation.
Li YH; Kuo CH; Shi GY; Wu HL
J Biomed Sci; 2012 Mar; 19(1):34. PubMed ID: 22449172
[TBL] [Abstract][Full Text] [Related]
11. The fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C.
Yang L; Rezaie AR
J Biol Chem; 2003 Mar; 278(12):10484-90. PubMed ID: 12529320
[TBL] [Abstract][Full Text] [Related]
12. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of an End-to-End Protein-Glycopolymer Conjugate via Bio-Orthogonal Chemistry.
Zhang H; Weingart J; Gruzdys V; Sun XL
ACS Macro Lett; 2016 Jan; 5(1):73-77. PubMed ID: 35668582
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
[TBL] [Abstract][Full Text] [Related]
15. Thrombomodulin.
Weiler H; Isermann BH
J Thromb Haemost; 2003 Jul; 1(7):1515-24. PubMed ID: 12871287
[TBL] [Abstract][Full Text] [Related]
16. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
17. Thrombin cleaves recombinant soluble thrombomodulin into a lectin-like domain fragment and a fragment with protein C-activating cofactor activity.
Yokoyama H; Tateishi K; Baba Y; Kobayashi A; Hashimoto M; Fukuda S; Yamao H; Maruyama T; Nakata M; Matsushita M
Biosci Trends; 2022 Dec; 16(6):444-446. PubMed ID: 36450579
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, activity, and preliminary structure of the fourth EGF-like domain of thrombomodulin.
Meininger DP; Hunter MJ; Komives EA
Protein Sci; 1995 Sep; 4(9):1683-95. PubMed ID: 8528067
[TBL] [Abstract][Full Text] [Related]
19. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
20. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
Tripodi A
Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
